Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
The “Highlights REAL” campaign, which Bayer kicked off Thursday, stars Romo, who played for the Dallas Cowboys before ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
GlobalData on MSN
Telix doses first patient in TLX591-Px prostate imaging trial
Up to 105 Japanese men will be enrolled at 11 sites, with data aimed at supporting a future marketing authorisation ...
In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
Italy: Patients with prostate cancer receiving maximal androgen blockade therapy face a significantly higher risk of bone fractures compared with those treated with androgen deprivation therapy alone, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the ...
Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results